TNFSF10 and colitis: In contrast, TRAIL directly inhibited activation of colitogenic T cells and development of gut inflammation in an adoptive transfer-induced colitis model, indicating a novel role for TRAIL in regulating autoreactive T-cell activation and modulating autoimmune colitis.